Description

Pharmaceutical companies that are not researching new antibiotics should face fines if the industry fails to agree a deal with the government within six months, a leading government adviser on superbugs has said.

Period26 Jan 2019

Media contributions

1

Media contributions

  • TitleDrug firms face fines for lack of antibiotic action
    Media name/outletThe Times
    Country/TerritoryUnited Kingdom
    Date26/01/19
    PersonsMark Woolhouse